1. Codman EA. Rupture of the Supraspinatus Tendon and Other Lesions in or about the Subacromial Bursa. The Shoulder 1934.
2. Reeves B. The natural history of the frozen shoulder syndrome. Scandinavian journal of rheumatology 1975;4:193-6.
3. Wong CK, Levine WN, Deo K, et al. Natural history of frozen shoulder: fact or fiction? A systematic review. Physiotherapy 2017;103:40-7.
4. Bunker TD, Anthony PP. The pathology of frozen shoulder. A Dupuytren-like disease. The Journal of bone and joint surgery British volume 1995;77:677-83.
5. Hand GC, Athanasou NA, Matthews T, Carr AJ. The pathology of frozen shoulder. The Journal of bone and joint surgery British volume 2007;89:928-32.
6. Rodeo SA, Hannafin JA, Tom J, Warren RF, Wickiewicz TL. Immunolocalization of cytokines and their receptors in adhesive capsulitis of the shoulder. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 1997;15:427-36.
7. Hagiwara Y, Ando A, Chimoto E, Saijo Y, Ohmori-Matsuda K, Itoi E. Changes of articular cartilage after immobilization in a rat knee contracture model. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2009;27:236-42.
8. Hagiwara Y, Ando A, Onoda Y, et al. Coexistence of fibrotic and chondrogenic process in the capsule of idiopathic frozen shoulders. Osteoarthritis and cartilage 2012;20:241-9.
9. Hagiwara Y, Mori M, Kanazawa K, et al. Comparative proteome analysis of the capsule from patients with frozen shoulder. Journal of shoulder and elbow surgery 2018;27:1770-8.
10. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001;44:129-46.
11. Tessier FJ. The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathologie-biologie 2010;58:214-9.
12. Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2010;21:195-214.
13. Vaculik J, Braun M, Dungl P, Pavelka K, Stepan JJ. Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis. BMC musculoskeletal disorders 2016;17:308.
14. Hwang KR, Murrell GA, Millar NL, Bonar F, Lam P, Walton JR. Advanced glycation end products in idiopathic frozen shoulders. Journal of shoulder and elbow surgery 2016;25:981-8.
15. Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. The Journal of biological chemistry 1992;267:14998-5004.
16. Huttunen HJ, Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease. Journal of internal medicine 2004;255:351-66.
17. Hori O, Brett J, Slattery T, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co- expression of rage and amphoterin in the developing nervous system. The Journal of biological chemistry 1995;270:25752-61.
18. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochemical and biophysical research communications 2004;322:1111-22.
19. Ostendorp T, Leclerc E, Galichet A, et al. Structural and functional insights into RAGE activation by multimeric S100B. The EMBO journal 2007;26:3868-78.
20. Fukami K, Yamagishi S, Okuda S. Role of AGEs-RAGE system in cardiovascular disease. Current pharmaceutical design 2014;20:2395-402.
21. Yan SF, Harja E, Andrassy M, Fujita T, Schmidt AM. Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis. Journal of the American College of Cardiology 2006;48:A47-55.
22. Vedantham S, Thiagarajan D, Ananthakrishnan R, et al. Aldose reductase drives hyperacetylation of Egr-1 in hyperglycemia and consequent upregulation of proinflammatory and prothrombotic signals. Diabetes 2014;63:761-74.
23. Yao J, Mackman N, Edgington TS, Fan ST. Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF- kappaB transcription factors. The Journal of biological chemistry 1997;272:17795-801.
24. Koyama H, Nishizawa Y. AGEs/RAGE in CKD: irreversible metabolic memory road toward CVD? European journal of clinical investigation 2010;40:623-35.
25. Gangemi S, Casciaro M, Trapani G, et al. Association between HMGB1 and COPD: A Systematic Review. Mediators of inflammation 2015;2015:164913.
26. Sha Y, Zmijewski J, Xu Z, Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. Journal of immunology (Baltimore, Md : 1950) 2008;180:2531-7.
27. Urbonaviciute V, Furnrohr BG, Meister S, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. The Journal of experimental medicine 2008;205:3007-18.
28. Zhang C, Dong H, Chen F, Wang Y, Ma J, Wang G. The HMGB1-RAGE/TLR-TNF- alpha signaling pathway may contribute to kidney injury induced by hypoxia. Experimental and therapeutic medicine 2019;17:17-26.
29. Rosenberg JH, Rai V, Dilisio MF, Agrawal DK. Damage-associated molecular patterns in the pathogenesis of osteoarthritis: potentially novel therapeutic targets. Molecular and cellular biochemistry 2017;434:171-9.
30. Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999;97:889-901.
31. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. The Journal of biological chemistry 2000;275:40096-105.
32. Sun XH, Liu Y, Han Y, Wang J. Expression and Significance of High-Mobility Group Protein B1 (HMGB1) and the Receptor for Advanced Glycation End-Product (RAGE) in Knee Osteoarthritis. Medical science monitor : international medical journal of experimental and clinical research 2016;22:2105-12.
33. Thankam FG, Dilisio MF, Dietz NE, Agrawal DK. TREM-1, HMGB1 and RAGE in the Shoulder Tendon: Dual Mechanisms for Inflammation Based on the Coincidence of Glenohumeral Arthritis. PloS one 2016;11:e0165492.
34. Hagiwara Y, Sekiguchi T, Ando A, et al. Effects of Arthroscopic Coracohumeral Ligament Release on Range of Motion for Patients with Frozen Shoulder. The open orthopaedics journal 2018;12:373-9.
35. Arai R, Nimura A, Yamaguchi K, et al. The anatomy of the coracohumeral ligament and its relation to the subscapularis muscle. Journal of shoulder and elbow surgery 2014;23:1575-81.
36. Passanante GJ, Skalski MR, Patel DB, et al. Inferior glenohumeral ligament (IGHL) complex: anatomy, injuries, imaging features, and treatment options. Emergency radiology 2017;24:65-71.
37. Tamborrini G, Moller I, Bong D, et al. The Rotator Interval - A Link Between Anatomy and Ultrasound. Ultrasound international open 2017;3:E107-e16.
38. Kanazawa K, Hagiwara Y, Kawai N, et al. Correlations of coracohumeral ligament and range of motion restriction in patients with recurrent anterior glenohumeral instability evaluated by magnetic resonance arthrography. Journal of shoulder and elbow surgery 2017;26:233-40.
39. Hagiwara Y, Ando A, Kanazawa K, et al. Arthroscopic Coracohumeral Ligament Release for Patients With Frozen Shoulder. Arthroscopy techniques 2018;7:e1-e5.
40. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic acids research 2001;29:e45.
41. Takeuchi M, Makita Z, Yanagisawa K, Kameda Y, Koike T. Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients. Molecular medicine (Cambridge, Mass) 1999;5:393-405.
42. Odetti P, Fogarty J, Sell DR, Monnier VM. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992;41:153-9.
43. Takahashi M, Hoshino H, Kushida K, Kawana K, Inoue T. Direct quantification of pentosidine in urine and serum by HPLC with column switching. Clinical chemistry 1996;42:1439-44.
44. Sell DR, Monnier VM. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. The Journal of biological chemistry 1989;264:21597-602.
45. Trudel G, Uhthoff HK. Contractures secondary to immobility: is the restriction articular or muscular? An experimental longitudinal study in the rat knee. Archives of physical medicine and rehabilitation 2000;81:6-13.
46. Kelley MJ, McClure PW, Leggin BG. Frozen shoulder: evidence and a proposed model guiding rehabilitation. The Journal of orthopaedic and sports physical therapy 2009;39:135-48.
47. Buchbinder R, Youd JM, Green S, et al. Efficacy and cost-effectiveness of physiotherapy following glenohumeral joint distension for adhesive capsulitis: a randomized trial. Arthritis and rheumatism 2007;57:1027-37.
48. Izumi T, Aoki M, Tanaka Y, et al. Stretching positions for the coracohumeral ligament: Strain measurement during passive motion using fresh/frozen cadaver shoulders. Sports medicine, arthroscopy, rehabilitation, therapy & technology : SMARTT 2011;3:2.
49. Neer CS, 2nd, Satterlee CC, Dalsey RM, Flatow EL. The anatomy and potential effects of contracture of the coracohumeral ligament. Clinical orthopaedics and related research 1992:182-5.
50. Ozaki J, Nakagawa Y, Sakurai G, Tamai S. Recalcitrant chronic adhesive capsulitis of the shoulder. Role of contracture of the coracohumeral ligament and rotator interval in pathogenesis and treatment. The Journal of bone and joint surgery American volume 1989;71:1511-5.
51. Okuno Y, Iwamoto W, Matsumura N, et al. Clinical Outcomes of Transcatheter Arterial Embolization for Adhesive Capsulitis Resistant to Conservative Treatment. Journal of vascular and interventional radiology : JVIR 2017;28:161-7.e1.
52. Clarke GR, Willis LA, Fish WW, Nichols PJ. Preliminary studies in measuring range of motion in normal and painful stiff shoulders. Rheumatology and rehabilitation 1975;14:39-46.
53. Sun Y, Zhang P, Liu S, et al. Intra-articular Steroid Injection for Frozen Shoulder: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis. The American journal of sports medicine 2017;45:2171-9.
54. Huri G, Kaymakoglu M, Garbis N. Rotator cable and rotator interval: anatomy, biomechanics and clinical importance. EFORT open reviews 2019;4:56-62.
55. Itoi E. Rotator cuff tear: physical examination and conservative treatment. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2013;18:197-204.
56. Mosca MJ, Carr AJ, Snelling SJB, Wheway K, Watkins B, Dakin SG. Differential expression of alarmins-S100A9, IL-33, HMGB1 and HIF-1alpha in supraspinatus tendinopathy before and after treatment. BMJ open sport & exercise medicine 2017;3:e000225.
57. Lee S, Sakurai T, Ohsako M, Saura R, Hatta H, Atomi Y. Tissue stiffness induced by prolonged immobilization of the rat knee joint and relevance of AGEs (pentosidine). Connective tissue research 2010;51:467-77.
58. Holte KB, Juel NG, Brox JI, et al. Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study. Journal of diabetes and its complications 2017;31:1408-14.
59. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. The Journal of biological chemistry 1991;266:11654- 60.
60. Fu MX, Requena JR, Jenkins AJ, Lyons TJ, Baynes JW, Thorpe SR. The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. The Journal of biological chemistry 1996;271:9982-6.
61. Kislinger T, Fu C, Huber B, et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. The Journal of biological chemistry 1999;274:31740-9.
62. Boelke E, Storck M, Buttenschoen K, Berger D, Hannekum A. Endotoxemia and mediator release during cardiac surgery. Angiology 2000;51:743-9.
63. Mazzini GS, Schaf DV, Oliveira AR, et al. The ischemic rat heart releases S100B. Life sciences 2005;77:882-9.
64. Villegas-Rodriguez ME, Uribarri J, Solorio-Meza SE, et al. The AGE-RAGE Axis and Its Relationship to Markers of Cardiovascular Disease in Newly Diagnosed Diabetic Patients. PloS one 2016;11:e0159175.
65. Ehlermann P, Eggers K, Bierhaus A, et al. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovascular diabetology 2006;5:6.
66. Luan ZG, Zhang H, Yang PT, Ma XC, Zhang C, Guo RX. HMGB1 activates nuclear factor-kappaB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology 2010;215:956-62.
67. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. The Journal of biological chemistry 2000;275:25781-90.
68. Kierdorf K, Fritz G. RAGE regulation and signaling in inflammation and beyond. Journal of leukocyte biology 2013;94:55-68.
69. Thomas SJ, McDougall C, Brown ID, et al. Prevalence of symptoms and signs of shoulder problems in people with diabetes mellitus. Journal of shoulder and elbow surgery 2007;16:748-51.
70. Ando A, Sugaya H, Hagiwara Y, et al. Identification of prognostic factors for the nonoperative treatment of stiff shoulder. International orthopaedics 2013;37:859-64.
71. Kanbe K, Inoue K, Inoue Y, Chen Q. Inducement of mitogen-activated protein kinases in frozen shoulders. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2009;14:56-61.
72. Hagiwara Y, Kanazawa K, Ando A, et al. Blood flow changes of the anterior humeral circumflex artery decrease with the scapula in internal rotation. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 2015;23:1467-72.
73. Silverman ES, Collins T. Pathways of Egr-1-mediated gene transcription in vascular biology. The American journal of pathology 1999;154:665-70.
74. Chang JS, Wendt T, Qu W, et al. Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products. Circulation research 2008;102:905-13.
75. Zhang K, Cao J, Dong R, Du J. Early growth response protein 1 promotes restenosis by upregulating intercellular adhesion molecule-1 in vein graft. Oxidative medicine and cellular longevity 2013;2013:432409.
76. Shi L, Kishore R, McMullen MR, Nagy LE. Lipopolysaccharide stimulation of ERK1/2 increases TNF-alpha production via Egr-1. American journal of physiology Cell physiology 2002;282:C1205-11.
77. Pawlinski R, Pedersen B, Kehrle B, et al. Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. Blood 2003;101:3940-7.
78. Bhattacharyya S, Chen SJ, Wu M, et al. Smad-independent transforming growth factor- beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma. The American journal of pathology 2008;173:1085-99.
79. Chavakis T, Bierhaus A, Al-Fakhri N, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. The Journal of experimental medicine 2003;198:1507-15.
80. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications. Atherosclerosis 2008;196:9-21.
81. Venereau E, Ceriotti C, Bianchi ME. DAMPs from Cell Death to New Life. Frontiers in immunology 2015;6:422.
82. Valencia JV, Mone M, Koehne C, Rediske J, Hughes TE. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia 2004;47:844-52.
83. Arcuri C, Giambanco I, Bianchi R, Donato R. Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles. Neuroscience 2002;109:371-88.
84. Tubaro C, Arcuri C, Giambanco I, Donato R. S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression. Journal of cellular physiology 2010;223:270-82.
85. Cao T, Zhang L, Yao LL, et al. S100B promotes injury-induced vascular remodeling through modulating smooth muscle phenotype. Biochimica et biophysica acta Molecular basis of disease 2017;1863:2772-82.
86. Bucciarelli LG, Wendt T, Qu W, et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 2002;106:2827-35.
87. Wannamethee SG, Welsh P, Papacosta O, et al. Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Atherosclerosis 2017;264:36-43.
88. Zaki M, Kamal S, Kholousi S, et al. Serum soluble receptor of advanced glycation end products and risk of metabolic syndrome in Egyptian obese women. EXCLI journal 2017;16:973- 80.
89. Wang X, Xu T, Mungun D, et al. The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease. Disease markers 2019;2019:4528382.
90. Oh S, Son M, Choi J, Lee S, Byun K. sRAGE prolonged stem cell survival and suppressed RAGE-related inflammatory cell and T lymphocyte accumulations in an Alzheimer's disease model. Biochemical and biophysical research communications 2018;495:807-13.
91. Ahmad S, Khan H, Siddiqui Z, et al. AGEs, RAGEs and s-RAGE; friend or foe for cancer. Seminars in cancer biology 2018;49:44-55.
92. Shen C, Ma Y, Zeng Z, et al. RAGE-Specific Inhibitor FPS-ZM1 Attenuates AGEs- Induced Neuroinflammation and Oxidative Stress in Rat Primary Microglia. Neurochemical research 2017;42:2902-11.
93. Cheng YZ, Yang SL, Wang JY, et al. Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway. Life sciences 2018;205:184-92.
94. Wang Z, Zhang J, Chen L, Li J, Zhang H, Guo X. Glycine Suppresses AGE/RAGE Signaling Pathway and Subsequent Oxidative Stress by Restoring Glo1 Function in the Aorta of Diabetic Rats and in HUVECs. Oxidative medicine and cellular longevity 2019;2019:4628962.
95. Chen M, Curtis TM, Stitt AW. Advanced glycation end products and diabetic retinopathy. Current medicinal chemistry 2013;20:3234-40.
96. Ahmed N, Thornalley PJ. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes, obesity & metabolism 2007;9:233-45.
97. Xiong DD, Zhang M, Li N, Gai JF, Mao L, Li M. Mediation of inflammation, obesity and fatty liver disease by advanced glycation endoproducts. European review for medical and pharmacological sciences 2017;21:5172-8.
98. Kamtchueng Simo O, Ikhlef S, Berrougui H, Khalil A. Advanced glycation end products affect cholesterol homeostasis by impairing ABCA1 expression on macrophages. Canadian journal of physiology and pharmacology 2017;95:977-84.
99. Chen XJ, Gong XH, Jie JP, et al. Receptor for advanced glycation end products reveals a mechanism regulating thyroid hormone secretion through the SIRT1/Nrf2 pathway. Journal of cellular biochemistry 2019;120:4582-98.
100. Giannakou M, Saltiki K, Mantzou E, et al. RAGE polymorphisms and oxidative stress levels in Hashimoto's thyroiditis. European journal of clinical investigation 2017;47:341-7.
論文の公開元へ
